An update on the CONCORDE study: a phase Ib platform study of DNA damage repair inhibitors (DDRIs) in combination with conventional radiotherapy in NSCLC

Horne, A., Walls, G., Brown, S. et al. (17 more authors) (2025) An update on the CONCORDE study: a phase Ib platform study of DNA damage repair inhibitors (DDRIs) in combination with conventional radiotherapy in NSCLC. In: Journal of Thoracic Oncology. European Lung Cancer Congress 2025, 26-29 Mar 2025, Paris, France. Elsevier BV , S150.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • Horne, A.
  • Walls, G.
  • Brown, S.
  • Chalmers, A.
  • Franks, K.
  • Harrow, S.
  • Hassani, A.
  • Hatton, M. ORCID logo https://orcid.org/0000-0003-2778-7926
  • Hiley, C.
  • Kendall, J.
  • Mcaleese, J.
  • Norris, M.
  • Ojo, O.
  • Oughton, J.
  • Phillip, R.
  • Rudd, P.
  • Shaw, P.
  • Walker, F.
  • Greystoke, A.
  • Faivre-Finn, C.
Copyright, Publisher and Additional Information:

© 2025 International Association for the Study of Lung Cancer
Dates:
  • Published (online): March 2025
  • Published: March 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 14 Jul 2025 15:12
Last Modified: 14 Jul 2025 15:12
Status: Published
Publisher: Elsevier BV
Identification Number: 10.1016/S1556-0864(25)00431-9
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)